233 related articles for article (PubMed ID: 31046175)
1. Anticholinergic medicines use among older adults before and after initiating dementia medicines.
Narayan SW; Pearson SA; Litchfield M; Le Couteur DG; Buckley N; McLachlan AJ; Zoega H
Br J Clin Pharmacol; 2019 Sep; 85(9):1957-1963. PubMed ID: 31046175
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous usage of dementia medications and anticholinergics among Asians and Pacific Islanders.
Schultz BR; Takeshita J; Goebert D; Takeshita S; Lu BY; Guilloux A; Higa J
Psychogeriatrics; 2017 Nov; 17(6):423-429. PubMed ID: 28387023
[TBL] [Abstract][Full Text] [Related]
3. Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease.
Mantri S; Fullard M; Gray SL; Weintraub D; Hubbard RA; Hennessy S; Willis AW
JAMA Neurol; 2019 Jan; 76(1):41-49. PubMed ID: 30285047
[TBL] [Abstract][Full Text] [Related]
4. Potentially inappropriate prescribing in people with dementia: An Australian population-based study.
Eshetie TC; Nguyen TA; Gillam MH; Kalisch Ellett LM
Int J Geriatr Psychiatry; 2019 Oct; 34(10):1498-1505. PubMed ID: 31173395
[TBL] [Abstract][Full Text] [Related]
5. Use of anticholinergic medications by older adults with dementia.
Roe CM; Anderson MJ; Spivack B
J Am Geriatr Soc; 2002 May; 50(5):836-42. PubMed ID: 12028169
[TBL] [Abstract][Full Text] [Related]
6. A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs.
Gill SS; Mamdani M; Naglie G; Streiner DL; Bronskill SE; Kopp A; Shulman KI; Lee PE; Rochon PA
Arch Intern Med; 2005 Apr; 165(7):808-13. PubMed ID: 15824303
[TBL] [Abstract][Full Text] [Related]
7. Anticholinergic burden before and after hospitalization in older adults with dementia: Increase due to antipsychotic medications.
Reinold J; Palese F; Romanese F; Logroscino G; Riedel O; Pisa FE
Int J Geriatr Psychiatry; 2019 Jun; 34(6):868-880. PubMed ID: 30761624
[TBL] [Abstract][Full Text] [Related]
8. Anticholinergic co-prescribing in nursing home residents using cholinesterase inhibitors: Potential deprescribing cascade.
Gromek KR; Thorpe CT; Aspinall SL; Hanson LC; Niznik JD
J Am Geriatr Soc; 2023 Jan; 71(1):77-88. PubMed ID: 36206324
[TBL] [Abstract][Full Text] [Related]
9. Potentially inappropriate prescribing before and after initiation of medicines for dementia: An Australian population-based study.
Eshetie TC; Nguyen TA; Gillam MH; Kalisch Ellett LM
Geriatr Gerontol Int; 2019 Jul; 19(7):654-659. PubMed ID: 31074090
[TBL] [Abstract][Full Text] [Related]
10. [Drugs used for cognitive impairment. Analysis of 1.5 million prescriptions in Argentina].
Rojas G; Demey I; Arizaga RL
Medicina (B Aires); 2013; 73(3):213-23. PubMed ID: 23732196
[TBL] [Abstract][Full Text] [Related]
11. [Patterns of antidemential drug use in a group of patients from Colombia].
Calvo-Torres LF; Bernal-Cobo R; Trujillo-Quintero PM; Gaviria-Mendoza A; Machado-Alba JE
Rev Neurol; 2019 May; 68(10):409-416. PubMed ID: 31070232
[TBL] [Abstract][Full Text] [Related]
12. Concomitant use of anticholinergics with acetylcholinesterase inhibitors in Medicaid recipients with dementia and residing in nursing homes.
Modi A; Weiner M; Craig BA; Sands LP; Rosenman MB; Thomas J
J Am Geriatr Soc; 2009 Jul; 57(7):1238-44. PubMed ID: 19467148
[TBL] [Abstract][Full Text] [Related]
13. Changes in utilisation of anticholinergic drugs after initiation of cholinesterase inhibitors.
Robinson M; Rowett D; Leverton A; Mabbott V
Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):659-64. PubMed ID: 19548222
[TBL] [Abstract][Full Text] [Related]
14. Anticholinergic and sedative medicines - prescribing considerations for people with dementia.
Bell JS; Mezrani C; Blacker N; LeBlanc T; Frank O; Alderman CP; Rossi S; Rowett D; Shute R
Aust Fam Physician; 2012; 41(1-2):45-9. PubMed ID: 22276284
[TBL] [Abstract][Full Text] [Related]
15. Prescription of Antidementia Drugs and Antipsychotics for Elderly Patients in Japan: A Descriptive Study Using Pharmacy Prescription Data.
Tsukada T; Sato I; Matsuoka N; Imai T; Doi Y; Arai M; Fujii Y; Matsunaga T; Kawakami K
J Geriatr Psychiatry Neurol; 2018 Jul; 31(4):194-202. PubMed ID: 30016896
[TBL] [Abstract][Full Text] [Related]
16. Factors Associated With Deprescribing Acetylcholinesterase Inhibitors in Older Nursing Home Residents With Severe Dementia.
Niznik JD; Zhao X; He M; Aspinall SL; Hanlon JT; Nace D; Thorpe JM; Thorpe CT
J Am Geriatr Soc; 2019 Sep; 67(9):1871-1879. PubMed ID: 31162642
[TBL] [Abstract][Full Text] [Related]
17. [Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine].
Sicras-Mainar A; Vergara J; Leon-Colombo T; Febrer L; Rejas-Gutierrez J
Rev Neurol; 2006 Oct 16-31; 43(8):449-53. PubMed ID: 17033976
[TBL] [Abstract][Full Text] [Related]
18. Anticholinergic Drug Burden in Persons with Dementia Taking a Cholinesterase Inhibitor: The Effect of Multiple Physicians.
Reppas-Rindlisbacher CE; Fischer HD; Fung K; Gill SS; Seitz D; Tannenbaum C; Austin PC; Rochon PA
J Am Geriatr Soc; 2016 Mar; 64(3):492-500. PubMed ID: 27000323
[TBL] [Abstract][Full Text] [Related]
19. A population-based study of dosing and persistence with anti-dementia medications.
Brewer L; Bennett K; McGreevy C; Williams D
Eur J Clin Pharmacol; 2013 Jul; 69(7):1467-75. PubMed ID: 23443628
[TBL] [Abstract][Full Text] [Related]
20. Use of Medicines with Anticholinergic and Sedative Effect Before and After Initiation of Anti-Dementia Medications.
Gadzhanova S; Roughead E; Robinson M
Drugs Real World Outcomes; 2015 Mar; 2(1):53-60. PubMed ID: 27747617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
